← AbbVie Inc.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net earnings $6.0b $5.3b $5.7b $7.9b $4.6b $11.5b $11.8b $4.9b $4.3b $4.2b
Net Income (Loss) Attributable to Parent $6.0b $5.3b $5.7b $7.9b $4.6b $11.5b $11.8b $4.9b $4.3b $4.2b
Net Income (Loss) Available to Common Stockholders, Basic $5.9b $5.3b $5.7b $7.8b $4.6b $11.5b $11.8b $4.8b $4.2b $4.2b
Net Income (Loss) Attributable to Noncontrolling Interest — — — — $6.0m $7.0m $9.0m $10.0m $8.0m $7.0m
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest — — — — $4.6b $11.5b $11.8b $4.9b $4.3b $4.2b
Amortization of Intangible Assets $764.0m $1.1b $1.3b $1.6b $5.8b $7.7b $7.7b $7.9b $7.6b $7.4b
Depreciation $425.0m $425.0m $471.0m $464.0m $666.0m $803.0m $778.0m $752.0m $764.0m $762.0m
Deferred Income Tax Expense (Benefit) ($796.0m) ($4.2b) ($1.5b) $122.0m ($2.3b) ($898.0m) ($1.9b) ($2.9b) ($1.4b) ($492.0m)
Deferred income taxes — — ($1.5b) $122.0m ($2.3b) ($898.0m) ($1.9b) ($2.9b) ($1.4b) ($492.0m)
Impairment of Intangible Assets (Excluding Goodwill) $39.0m $354.0m $5.1b $1.0b $0 $0 $770.0m $4.2b $4.5b $847.0m
Impairment of Intangible Assets, Finite-lived $39.0m $354.0m $0 $0 $0 $0 $770.0m $4.2b $4.5b $847.0m
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) $0 $0 $5.1b $1.0b $0 $0 $770.0m $4.2b $4.5b $847.0m
Impairment of intangible assets $39.0m $354.0m $5.1b $1.0b $0 $0 $770.0m $4.2b $4.5b $847.0m
Share-based Payment Arrangement, Expense $396.0m $365.0m $421.0m $430.0m $753.0m $692.0m $671.0m $747.0m $911.0m $955.0m
Share-based Payment Arrangement, Noncash Expense $353.0m $365.0m $421.0m $430.0m $753.0m $692.0m $671.0m $747.0m $911.0m $955.0m
Gain (Loss) on Disposition of Other Assets — — — $330.0m $0 $68.0m $172.0m $0 $0 —
Income Tax Expense (Benefit) $1.9b $2.4b ($490.0m) $544.0m ($1.2b) $1.4b $1.6b $1.4b ($570.0m) $2.4b
Other Nonoperating Income (Expense) ($232.0m) ($513.0m) ($18.0m) ($3.0b) ($5.6b) ($2.5b) ($2.4b) ($4.7b) ($3.2b) ($5.8b)
Changes in operating assets and liabilities:
Additional Financial Items
Accounts payable and other liabilities ($1.2b) $425.0m $190.0m ($1.1b) $1.5b $1.6b $1.6b $3.8b $177.0m $951.0m
Accounts receivable ($71.0m) ($391.0m) ($591.0m) ($74.0m) ($929.0m) ($1.3b) ($1.5b) $66.0m $207.0m ($1.5b)
Acquired IPR&D and milestones $280.0m $470.0m $1.1b $490.0m $1.4b $1.6b $697.0m $778.0m $2.8b $5.0b
Change in fair value of contingent consideration liabilities $228.0m $626.0m $49.0m $3.1b $5.8b $2.7b $2.8b $5.1b $3.8b $6.5b
Foreign Currency Transaction Gain (Loss), before Tax ($303.0m) ($348.0m) ($24.0m) ($42.0m) ($71.0m) ($51.0m) ($148.0m) ($146.0m) ($21.0m) ($58.0m)
Goodwill $15.4b $15.8b $15.7b $15.6b $33.1b $32.4b $32.2b $32.3b $35.0b $35.6b
Income tax assets and liabilities, net — — $674.0m ($1.0b) ($573.0m) ($1.3b) $542.0m ($488.0m) ($3.2b) ($762.0m)
Increase (Decrease) in Accounts Receivable $71.0m $391.0m $591.0m $74.0m $929.0m $1.3b $1.5b ($66.0m) ($207.0m) $1.5b
Increase (Decrease) in Inventories $38.0m ($93.0m) $226.0m $231.0m $40.0m $142.0m $686.0m $417.0m $319.0m $234.0m
Inventories ($38.0m) $93.0m ($226.0m) ($231.0m) ($40.0m) ($142.0m) ($686.0m) ($417.0m) ($319.0m) ($234.0m)
Net change in commercial paper borrowings with original maturities of three months or less ($23.0m) $23.0m $299.0m ($699.0m) $0 $0 — $0 $0 $499.0m
Non-cash litigation reserve adjustments, net of cash payments — — — — ($31.0m) $163.0m $2.2b ($443.0m) $508.0m ($933.0m)
Other, net $35.0m $22.0m $14.0m $35.0m $8.0m $24.0m $30.0m $48.0m $57.0m $68.0m
Payments of contingent consideration liabilities $0 ($268.0m) ($78.0m) ($163.0m) ($321.0m) ($698.0m) ($1.1b) ($752.0m) $0 $0
Prepaid expenses and other assets ($393.0m) ($118.0m) ($499.0m) $97.0m $134.0m ($197.0m) ($264.0m) ($188.0m) $361.0m ($827.0m)
Proceeds from Stock Options Exercised $268.0m $254.0m $73.0m $8.0m $209.0m $244.0m $262.0m $180.0m $214.0m $172.0m
Proceeds from the exercise of stock options $268.0m $254.0m $73.0m $8.0m $209.0m $244.0m $262.0m $180.0m $214.0m $172.0m
Purchases of treasury stock ($6.0b) ($1.4b) ($12.0b) ($629.0m) ($978.0m) ($934.0m) ($1.5b) ($2.0b) ($1.7b) ($980.0m)
Stock-based compensation $353.0m $365.0m $421.0m $430.0m $753.0m $692.0m $671.0m $747.0m $911.0m $955.0m
Derivative, Gain (Loss) on Derivative, Net ($252.0m) ($41.0m) — — — — — — — —
Other Operating Income (Expense), Net — — — $890.0m $0 ($432.0m) ($56.0m) $179.0m $7.0m $241.0m
Net Cash Provided by (Used in) Operating Activities $7.0b $10.0b $13.4b $13.3b $17.6b $22.8b $24.9b $22.8b $18.8b $19.0b
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $479.0m $529.0m $638.0m $552.0m $798.0m $787.0m $695.0m $777.0m $974.0m $1.2b
Acquisition of businesses, net of cash acquired ($2.5b) $0 $0 $0 ($38.3b) ($525.0m) ($255.0m) $0 ($17.5b) ($204.0m)
Payments to Acquire Businesses, Net of Cash Acquired $2.5b $0 $0 $0 $38.3b $525.0m $255.0m $0 $17.5b $204.0m
Other acquisitions and investments, net of cash acquired ($262.0m) ($308.0m) ($736.0m) ($1.1b) ($1.4b) ($1.4b) ($539.0m) ($1.2b) ($3.0b) ($5.2b)
Purchases of investment securities ($5.3b) ($2.2b) ($1.8b) ($583.0m) ($61.0m) ($119.0m) ($1.4b) ($77.0m) ($73.0m) ($35.0m)
Sales and maturities of investment securities $2.4b $2.8b $2.2b $2.7b $1.5b $98.0m $1.5b $55.0m $555.0m $76.0m
Payments for (Proceeds from) Other Investing Activities ($118.0m) $0 $0 ($167.0m) ($1.4b) ($366.0m) ($774.0m) ($13.0m) ($189.0m) $29.0m
Net Cash Provided by (Used in) Investing Activities ($6.1b) ($274.0m) ($1.0b) $596.0m ($37.6b) ($2.3b) ($623.0m) ($2.0b) ($20.8b) ($6.6b)
Cash flows from financing activities:
Debt issuance costs ($69.0m) $0 ($40.0m) ($424.0m) ($20.0m) $0 $0 ($38.0m) ($99.0m) ($23.0m)
Proceeds from Issuance of Long-term Debt $11.6b $0 $6.0b $31.5b $3.0b $1.0b $2.0b — $17.0b $4.0b
Proceeds from Short-Term Debt — — — — — — $0 $0 $5.0b $4.8b
Repayments of Other Short-Term Debt — $0 $0 ($3.0b) $0 $0 $0 $0 ($5.0b) ($2.8b)
Repayments of long-term debt and finance lease obligations ($6.0b) ($25.0m) ($6.0b) ($1.5b) ($5.7b) ($9.4b) ($14.4b) ($4.1b) ($9.6b) ($6.8b)
Payments for Repurchase of Common Stock $6.0b $1.4b $12.0b $629.0m $978.0m $934.0m $1.5b $2.0b $1.7b $980.0m
Dividends Payable, Current $1.0b $1.1b $1.6b $1.8b $2.3b $2.5b $2.7b $2.8b $2.9b $3.1b
Dividends paid $3.7b $4.1b $5.6b $6.4b $7.7b $9.3b $10.0b $10.5b $11.0b $11.7b
Proceeds from (Payments for) Other Financing Activities $35.0m $22.0m $14.0m $35.0m $8.0m $24.0m $30.0m $48.0m $57.0m $68.0m
Net Cash Provided by (Used in) Financing Activities ($3.9b) ($5.5b) ($14.4b) $18.7b ($11.5b) ($19.0b) ($24.8b) ($17.2b) ($5.2b) ($12.7b)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents ($338.0m) $29.0m ($39.0m) $7.0m ($5.0m) ($97.0m) ($62.0m) $5.0m ($65.0m) $42.0m
Effect of exchange rate changes on cash and equivalents ($338.0m) $29.0m ($39.0m) $7.0m ($5.0m) ($97.0m) ($62.0m) $5.0m ($65.0m) $42.0m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect ($338.0m) $29.0m ($39.0m) $7.0m ($31.5b) $1.3b ($545.0m) $3.6b ($7.3b) ($295.0m)
Cash and equivalents, beginning of year $8.4b $5.1b $9.3b $7.3b $8.4b $9.7b $9.2b $12.8b $5.5b $5.2b
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents — — — — $8.4b $9.7b $9.2b $12.8b $5.5b $5.2b
Net change in cash and equivalents ($3.3b) $4.2b ($2.0b) $32.6b ($31.5b) $1.3b ($545.0m) $3.6b ($7.3b) ($295.0m)
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities $986.0m $1.1b $1.2b $1.8b $2.6b $2.7b $2.5b $2.5b $2.8b $3.0b
Income Taxes Paid, Net — — — — — — — — — $3.6b

Data sourced from SEC EDGAR 10-K filings via EdgarTools. Amounts are shown in USD as reported in each fiscal year filing.

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.